Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer.

Segal NH, He AR, Doi T, Levy R, Bhatia S, Pishvaian MJ, Cesari R, Chen Y, Davis CB, Huang B, Thall AD, Gopal AK.

Clin Cancer Res. 2018 Apr 15;24(8):1816-1823. doi: 10.1158/1078-0432.CCR-17-1922. Epub 2018 Mar 16.

PMID:
29549159
2.

A New Proposal for Management of Severe Frostbite in the Austere Environment.

Cauchy E, Davis CB, Pasquier M, Meyer EF, Hackett PH.

Wilderness Environ Med. 2016 Mar;27(1):92-9. doi: 10.1016/j.wem.2015.11.014.

PMID:
26948558
3.

Medical Knowledge and Preparedness of Climbers on Colorado's 14,000-Foot Peaks.

Brandenburg WE, Davis CB.

Wilderness Environ Med. 2016 Mar;27(1):62-8. doi: 10.1016/j.wem.2015.11.009.

PMID:
26948555
4.

Avalanche Fatalities in the United States: A Change in Demographics.

Jekich BM, Drake BD, Nacht JY, Nichols A, Ginde AA, Davis CB.

Wilderness Environ Med. 2016 Mar;27(1):46-52. doi: 10.1016/j.wem.2015.11.004.

PMID:
26948553
5.

Two Horizontally Transferred Xenobiotic Resistance Gene Clusters Associated with Detoxification of Benzoxazolinones by Fusarium Species.

Glenn AE, Davis CB, Gao M, Gold SE, Mitchell TR, Proctor RH, Stewart JE, Snook ME.

PLoS One. 2016 Jan 25;11(1):e0147486. doi: 10.1371/journal.pone.0147486. eCollection 2016.

6.

Development of cultured Plasmodium falciparum blood-stage malaria cell banks for early phase in vivo clinical trial assessment of anti-malaria drugs and vaccines.

Stanisic DI, Liu XQ, De SL, Batzloff MR, Forbes T, Davis CB, Sekuloski S, Chavchich M, Chung W, Trenholme K, McCarthy JS, Li T, Sim BK, Hoffman SL, Good MF.

Malar J. 2015 Apr 7;14:143. doi: 10.1186/s12936-015-0663-x.

7.

Whole-Genome Sequences of 80 Environmental and Clinical Isolates of Burkholderia pseudomallei.

Johnson SL, Baker AL, Chain PS, Currie BJ, Daligault HE, Davenport KW, Davis CB, Inglis TJ, Kaestli M, Koren S, Mayo M, Merritt AJ, Price EP, Sarovich DS, Warner J, Rosovitz MJ.

Genome Announc. 2015 Feb 12;3(1). pii: e01282-14. doi: 10.1128/genomeA.01282-14.

8.

"Quasi nonparametric" upper tolerance limits for occupational exposure evaluations.

Davis CB, Wambach PF.

J Occup Environ Hyg. 2015;12(5):342-9. doi: 10.1080/15459624.2014.995301.

PMID:
25647534
9.

Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging.

Zeglis BM, Davis CB, Abdel-Atti D, Carlin SD, Chen A, Aggeler R, Agnew BJ, Lewis JS.

Bioconjug Chem. 2014 Dec 17;25(12):2123-8. doi: 10.1021/bc500499h. Epub 2014 Nov 26.

10.

Anticoagulant-induced hemarthrosis presenting as anterior shoulder dislocation.

Davis CB, Nowak RM.

Am J Emerg Med. 2014 Dec;32(12):1562.e3-4. doi: 10.1016/j.ajem.2014.05.042. Epub 2014 Jun 2.

PMID:
25043625
11.

Employee perception of a mandated helmet policy at Vail Resorts.

Davis CB, Brownson MR, Levy BJ, Valley MA, Evans B, Lowenstein SR.

Wilderness Environ Med. 2013 Dec;24(4):402-6. doi: 10.1016/j.wem.2013.06.001. Epub 2013 Aug 31.

PMID:
24001389
12.

Emergency bedside ultrasound diagnosis of superior mesenteric artery dissection complicating acute aortic dissection.

Davis CB, Kendall JL.

J Emerg Med. 2013 Dec;45(6):894-6. doi: 10.1016/j.jemermed.2013.04.025. Epub 2013 Aug 6.

PMID:
23932465
13.

Enzyme-mediated methodology for the site-specific radiolabeling of antibodies based on catalyst-free click chemistry.

Zeglis BM, Davis CB, Aggeler R, Kang HC, Chen A, Agnew BJ, Lewis JS.

Bioconjug Chem. 2013 Jun 19;24(6):1057-67. doi: 10.1021/bc400122c. Epub 2013 May 30.

14.

Rational Design, Synthesis, and SAR of a Novel Thiazolopyrimidinone Series of Selective PI3K-beta Inhibitors.

Lin H, Schulz MJ, Xie R, Zeng J, Luengo JI, Squire MD, Tedesco R, Qu J, Erhard K, Mack JF, Raha K, Plant R, Rominger CM, Ariazi JL, Sherk CS, Schaber MD, McSurdy-Freed J, Spengler MD, Davis CB, Hardwicke MA, Rivero RA.

ACS Med Chem Lett. 2012 May 29;3(7):524-9. doi: 10.1021/ml300045b. eCollection 2012 Jul 12.

15.

Demand forecasting and capacity management in primary care.

Heroman WM, Davis CB, Farmer KL Jr.

Physician Exec. 2012 Jan-Feb;38(1):30-4. No abstract available.

PMID:
23885507
16.

Poor agreement of prostate specific antigen doubling times calculated using ultrasensitive versus standard prostate specific antigen values: important impact on risk assessment.

Reese AC, Fradet V, Whitson JM, Davis CB, Carroll PR.

J Urol. 2011 Dec;186(6):2228-32. doi: 10.1016/j.juro.2011.07.119. Epub 2011 Oct 19.

PMID:
22014796
17.

Differences in effects on myocardium and mitochondria by angiogenic inhibitors suggest separate mechanisms of cardiotoxicity.

French KJ, Coatney RW, Renninger JP, Hu CX, Gales TL, Zhao S, Storck LM, Davis CB, McSurdy-Freed J, Chen E, Frazier KS.

Toxicol Pathol. 2010 Aug;38(5):691-702. doi: 10.1177/0192623310373775. Epub 2010 Jul 8.

PMID:
20616376
18.

Incidence of bladder neck contracture after robot-assisted laparoscopic and open radical prostatectomy.

Breyer BN, Davis CB, Cowan JE, Kane CJ, Carroll PR.

BJU Int. 2010 Dec;106(11):1734-8. doi: 10.1111/j.1464-410X.2010.09333.x.

19.

Interaction of macrolide antibiotics with intestinally expressed human and rat organic anion-transporting polypeptides.

Lan T, Rao A, Haywood J, Davis CB, Han C, Garver E, Dawson PA.

Drug Metab Dispos. 2009 Dec;37(12):2375-82. doi: 10.1124/dmd.109.028522. Epub 2009 Sep 9.

20.

Penile sonographic and clinical characteristics in men with Peyronie's disease.

Smith JF, Brant WO, Fradet V, Shindel AW, Vittinghoff E, Chi T, Huang YC, Davis CB, Conti S, Lue TF.

J Sex Med. 2009 Oct;6(10):2858-67. doi: 10.1111/j.1743-6109.2009.01438.x. Epub 2009 Aug 28.

PMID:
19732312
21.
22.

Prediction of animal clearance using naïve Bayesian classification and extended connectivity fingerprints.

McIntyre TA, Han C, Davis CB.

Xenobiotica. 2009 Jul;39(7):487-94. doi: 10.1080/00498250902926906.

PMID:
19480555
23.

Synthesis, antimalarial activity, and preclinical pharmacology of a novel series of 4'-fluoro and 4'-chloro analogues of amodiaquine. Identification of a suitable "back-up" compound for N-tert-butyl isoquine.

O'Neill PM, Shone AE, Stanford D, Nixon G, Asadollahy E, Park BK, Maggs JL, Roberts P, Stocks PA, Biagini G, Bray PG, Davies J, Berry N, Hall C, Rimmer K, Winstanley PA, Hindley S, Bambal RB, Davis CB, Bates M, Gresham SL, Brigandi RA, Gomez-de-Las-Heras FM, Gargallo DV, Parapini S, Vivas L, Lander H, Taramelli D, Ward SA.

J Med Chem. 2009 Apr 9;52(7):1828-44. doi: 10.1021/jm8012757.

24.

Candidate selection and preclinical evaluation of N-tert-butyl isoquine (GSK369796), an affordable and effective 4-aminoquinoline antimalarial for the 21st century.

O'Neill PM, Park BK, Shone AE, Maggs JL, Roberts P, Stocks PA, Biagini GA, Bray PG, Gibbons P, Berry N, Winstanley PA, Mukhtar A, Bonar-Law R, Hindley S, Bambal RB, Davis CB, Bates M, Hart TK, Gresham SL, Lawrence RM, Brigandi RA, Gomez-delas-Heras FM, Gargallo DV, Ward SA.

J Med Chem. 2009 Mar 12;52(5):1408-15. doi: 10.1021/jm8012618.

PMID:
19222165
25.

Immobilization and detection of DNA on microfluidic chips.

Shamansky LM, Davis CB, Stuart JK, Kuhr WG.

Talanta. 2001 Dec 13;55(5):909-18.

PMID:
18968441
26.

Involvement of intestinal uptake transporters in the absorption of azithromycin and clarithromycin in the rat.

Garver E, Hugger ED, Shearn SP, Rao A, Dawson PA, Davis CB, Han C.

Drug Metab Dispos. 2008 Dec;36(12):2492-8. doi: 10.1124/dmd.108.022285. Epub 2008 Aug 28.

27.

Differences in the total body clearance of lead compounds in the rat and mouse: impact on pharmacokinetic screening strategy.

McIntyre TA, Han C, Xiang H, Bambal R, Davis CB.

Xenobiotica. 2008 Jun;38(6):605-19. doi: 10.1080/00498250802001834 .

PMID:
18570161
28.

Comparative preclinical drug metabolism and pharmacokinetic evaluation of novel 4-aminoquinoline anti-malarials.

Davis CB, Bambal R, Moorthy GS, Hugger E, Xiang H, Park BK, Shone AE, O'Neill PM, Ward SA.

J Pharm Sci. 2009 Jan;98(1):362-77. doi: 10.1002/jps.21469.

PMID:
18563832
29.

Disaster preparedness for vulnerable persons receiving in-home, long-term care in South Carolina.

Laditka SB, Laditka JN, Cornman CB, Davis CB, Chandlee MJ.

Prehosp Disaster Med. 2008 Mar-Apr;23(2):133-42; discussion 143.

PMID:
18557293
30.

Pharmacokinetics and brain penetration of casopitant, a potent and selective neurokinin-1 receptor antagonist, in the ferret.

Minthorn E, Mencken T, King AG, Shu A, Rominger D, Gontarek RR, Han C, Bambal R, Davis CB.

Drug Metab Dispos. 2008 Sep;36(9):1846-52. doi: 10.1124/dmd.108.021758. Epub 2008 Jun 12.

31.

Impact of erythrocyte Duffy antigen genetic polymorphism on the distribution of GroBeta-T, a novel human CXC chemokine.

Hepburn TW, Tobia LP, Shi W, McIntyre TA, Davis CB.

J Pharm Pharm Sci. 2007;10(4):486-95.

PMID:
18396564
32.

Providing shelter to nursing home evacuees in disasters: lessons from Hurricane Katrina.

Laditka SB, Laditka JN, Xirasagar S, Cornman CB, Davis CB, Richter JV.

Am J Public Health. 2008 Jul;98(7):1288-93. doi: 10.2105/AJPH.2006.107748. Epub 2008 Jan 2.

33.

Validation of the Mortality in Emergency Department Sepsis (MEDS) score in patients with the systemic inflammatory response syndrome (SIRS).

Sankoff JD, Goyal M, Gaieski DF, Deitch K, Davis CB, Sabel AL, Haukoos JS.

Crit Care Med. 2008 Feb;36(2):421-6.

PMID:
18091538
34.

Determination of capsaicinoids in habanero peppers by chemometric analysis of UV spectral data.

Davis CB, Markey CE, Busch MA, Busch KW.

J Agric Food Chem. 2007 Jul 25;55(15):5925-33. Epub 2007 Jul 4.

PMID:
17608494
35.

Synthesis and biological evaluation of galactofuranosyl alkyl thioglycosides as inhibitors of mycobacteria.

Davis CB, Hartnell RD, Madge PD, Owen DJ, Thomson RJ, Chong AK, Coppel RL, von Itzstein M.

Carbohydr Res. 2007 Sep 3;342(12-13):1773-80. Epub 2007 May 6.

PMID:
17517379
36.

Protecting nursing home residents during emergencies or disasters: an exploratory study from South Carolina.

Laditka SB, Laditka JN, Xirasagar S, Cornman CB, Davis CB, Richter JV.

Prehosp Disaster Med. 2007 Jan-Feb;22(1):42-8.

PMID:
17484362
37.

Synthesis and evaluation of galactofuranosyl N,N-dialkyl sulfenamides and sulfonamides as antimycobacterial agents.

Owen DJ, Davis CB, Hartnell RD, Madge PD, Thomson RJ, Chong AK, Coppel RL, von Itzstein M.

Bioorg Med Chem Lett. 2007 Apr 15;17(8):2274-7. Epub 2007 Jan 27.

PMID:
17303419
38.

Impact of biological and economic variables on optimal parity for replacement in swine breed-to-wean herds.

Rodriguez-Zas SL, Davis CB, Ellinger PN, Schnitkey GD, Romine NM, Connor JF, Knox RV, Southey BR.

J Anim Sci. 2006 Sep;84(9):2555-65.

PMID:
16908661
39.

Preclinical drug metabolism and pharmacokinetic evaluation of GW844520, a novel anti-malarial mitochondrial electron transport inhibitor.

Xiang H, McSurdy-Freed J, Moorthy GS, Hugger E, Bambal R, Han C, Ferrer S, Gargallo D, Davis CB.

J Pharm Sci. 2006 Dec;95(12):2657-72.

PMID:
16892205
40.

Person-centered planning training for consumer-directed care for the elderly and disabled.

Davis CB, Cornman CB, Lane MJ, Patton M.

Care Manag J. 2005 Fall;6(3):122-30.

PMID:
16642686
41.

Effects of low-level hydrophobic substitution on conditioning properties of cationic cellulosic polymers in shampoo systems.

Drovetskaya TV, Kreeger RL, Amos JL, Davis CB, Zhou S.

J Cosmet Sci. 2004;55 Suppl:S195-205.

PMID:
15645097
42.

Independently-addressable micron-sized biosensor elements.

Davis CB, Shamansky LM, Rosenwald S, Stuart JK, Kuhr WG, Brazill SA.

Biosens Bioelectron. 2003 Sep;18(10):1299-307.

PMID:
12835048
43.

Immunocytokines: amplification of anti-cancer immunity.

Davis CB, Gillies SD.

Cancer Immunol Immunother. 2003 May;52(5):297-308. Epub 2003 Jan 31. Review.

PMID:
12700945
44.

Antibody-mediated stripping of CD4 from lymphocyte cell surface in patients with rheumatoid arthritis.

Hepburn TW, Totoritis MC, Davis CB.

Rheumatology (Oxford). 2003 Jan;42(1):54-61.

PMID:
12509613
45.

Pharmacokinetic and pharmacodynamic modeling of humanized anti-factor IX antibody (SB 249417) in humans.

Chow FS, Benincosa LJ, Sheth SB, Wilson D, Davis CB, Minthorn EA, Jusko WJ.

Clin Pharmacol Ther. 2002 Apr;71(4):235-45.

PMID:
11956506
46.

CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritis.

Mason U, Aldrich J, Breedveld F, Davis CB, Elliott M, Jackson M, Jorgensen C, Keystone E, Levy R, Tesser J, Totoritis M, Truneh A, Weisman M, Wiesenhutter C, Yocum D, Zhu J.

J Rheumatol. 2002 Feb;29(2):220-9.

PMID:
11838838
47.

Pharmacokinetics and tissue distribution of SB-251353, a novel human CXC chemokine, after intravenous administration to mice.

Hepburn TW, Hart TK, Horton VL, Sellers TS, Tobia LP, Urbanski JJ, Shi W, Davis CB.

J Pharmacol Exp Ther. 2001 Sep;298(3):886-93.

48.

Segregation of micrometer-dimension biosensor elements on a variety of substrate surfaces.

Brooks SA, Dontha N, Davis CB, Stuart JK, O'Neill G, Kuhr WG.

Anal Chem. 2000 Jul 15;72(14):3253-9.

PMID:
10939396
49.
50.

2,3-Dihydro-dithiin and -dithiepine-1,1,4,4-tetroxides: small molecule non-peptide antagonists of the human galanin hGAL-1 receptor.

Scott MK, Ross TM, Lee DH, Wang HY, Shank RP, Wild KD, Davis CB, Crooke JJ, Potocki AC, Reitz AB.

Bioorg Med Chem. 2000 Jun;8(6):1383-91.

PMID:
10896115

Supplemental Content

Loading ...
Support Center